Increasing numbers of studies indicate that the pathophysiological progression of Alzheimer's disease (AD) could be accelerated by chronic cerebral hypoperfusion (CCH). These findings suggest that cerebrovascular dysfunction may induce cognitive impairment in AD by expediting neurodegeneration. Dendrobium nobile Lindl. alkaloids (DNLA), the primary active components of Dendrobium nobile Lindl., have been shown to enhance cognitive function and exhibit neuroprotective effects in AD animal models.
Objective
However, the impact of DNLA on AD with CCH is still elusive.
Methods
In this study, we explored the therapeutic potential and underlying mechanisms of DNLA using a novel AD plus CCH mouse model.
Results
Our results demonstrate that DNLA significantly improved cerebral blood flow, attenuated motor and cognitive decline, reduced amyloid-β deposition, mitigated neuroinflammation, and alleviated neural oxidative stress in 12-month-old AD mice with CCH.
Conclusions
Our study suggests that DNLA exerts multiple neuroprotective effects, effectively preserving motor and cognitive function in AD with CCH mice of 12 months. Thus, DNLA represents a promising therapeutic candidate for the prevention and treatment of AD plus CCH.
HampelHHardyJBlennowK, et al.The amyloid-β pathway in Alzheimer’s disease. Mol Psychiatry2021; 26: 5481–5503.
2.
CogswellPMLundtESTherneauTM, et al.Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers. Nat Commun2023; 14: 3097.
3.
LorenziniLMaranzanoAIngalaS, et al.Association of vascular risk factors and cerebrovascular pathology with Alzheimer disease pathologic changes in individuals without dementia. Neurology2024; 103: e209801.
4.
BiesselsGJ. Alzheimer’s disease, cerebrovascular disease and dementia: lump, split or integrate?Brain2022; 145: 2632–2634.
5.
ZhaiYYamashitaTNakanoY, et al.Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with cerebrovascular remodeling in a novel mouse model. J Alzheimers Dis2016; 53: 893–905.
6.
FengTYamashitaTShangJ, et al.Clinical and pathological benefits of edaravone for Alzheimer's disease with chronic cerebral hypoperfusion in a novel mouse model. J Alzheimers Dis2019; 71: 327–339.
7.
FengTYamashitaTSasakiR, et al.Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion. J Cereb Blood Flow Metab2021; 41: 1437–1448.
8.
FengTHuXFukuiY, et al.Clinical and pathological benefits of scallop-derived plasmalogen in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfuion. J Alzheimers Dis2022; 86: 1973–1982.
9.
ZhaiYMoriharaRFengT, et al.Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion. Brain Res2024; 1828: 148790.
10.
ZhangWHuangJShiJ. Dendrobine ameliorates Alzheimer's disease-like pathology and cognitive decline in 3 × Tg-AD mice. Brain Sci2024; 14: 231.
11.
PiTLangGLiuB, et al.Protective effects of Dendrobium nobile Lindl. alkaloids on Alzheimer's disease-like symptoms induced by high-methionine diet. Curr Neuropharmacol2022; 20: 983–997.
12.
LiDDZhengCQZhangF, et al.Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models. Neural Regen Res2022; 17: 972–977.
13.
ShangJYamashitaTZhaiY, et al.Strong impact of chronic cerebral hypoperfusion on neurovascular unit, cerebrovascular remodeling, and neurovascular trophic coupling in Alzheimer's disease model mouse. J Alzheimers Dis2016; 52: 113–126.
14.
FengTYamashitaTZhaiY, et al.Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model. Brain Res2018; 1696: 63–70.
15.
WashidaKHattoriYIharaM. Animal models of chronic cerebral hypoperfusion: from mouse to primate. Int J Mol Sci2019; 20: 6176.
16.
Sturchler-PierratCAbramowskiDDukeM. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A1997; 94: 13287–13292.
17.
Sturchler-PierratCStaufenbielM. Pathogenic mechanisms of Alzheimer’s disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci2006; 920: 134–139.
18.
MachinDCampbellMJ. Medical statistics A commonsense approach: a textbook for health science. 4th ed. Hoboken: Wiley & Sons, 2007.
19.
FengTHuXFukuiY, et al.Neuroprotective effects of Scallop-derived plasmalogen in a mouse model of ischemic stroke. Brain Res2021; 1766: 147516.
20.
OkadaMTamuraAUraeA, et al.Long-term spatial cognitive impairment following middle cerebral artery occlusion in rats. A behavioral study. J Cereb Blood Flow Metab1995; 15: 505–512.
21.
KurataTMiyazakiKKozukiM, et al.Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Brain Res2011; 1371: 161–170.
22.
HishikawaNFukuiYSatoK, et al.Characteristic features of cognitive, affective and daily living functions of late-elderly dementia. Geriatr Gerontol Int2015; 16: 458–465.
23.
KislerKNelsonARMontagneA, et al.Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci2017; 18: 419–434.
24.
AshokARaiNKRazaW, et al.Chronic cerebral hypoperfusion-induced impairment of A clearance requires HB-EGF-dependent sequential activation of HIF1 and MMP9. Neurobiol Dis2016; 95: 179–193.
25.
BloomGS. Amyloid- and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol2014; 71: 505–508.
26.
WangY-J. Lessons from immunotherapy for Alzheimer disease. Nat Rev Neurol2014; 10: 188.
27.
NieXChenYLiW, et al.Anti-aging properties of Dendrobium nobile Lindl.: from molecular mechanisms to potential treatments. J Ethnopharmacol2020; 257: 112839.
28.
LiuBLiuJShiJS. SAMP8 Mice as a model of age-related cognition decline with underlying mechanisms in Alzheimer's disease. J Alzheimers Dis2020; 75: 385–395.
29.
LiuBHuangBLiuJ, et al.Dendrobium nobile Lindl alkaloid and metformin ameliorate cognitive dysfunction in senescence-accelerated mice via suppression of endoplasmic reticulum stress. Brain Res2020; 1741: 146871.
30.
HuangJHuangNZhangM, et al.Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats. PeerJ2019; 7: e7627.
31.
ShangJYamashitaTTianF, et al.Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse. Brain Res2019; 1723: 146379.
32.
ZhangWXiaoDMaoQ, et al.Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther2023; 8: 267.
33.
LengFEdisonP. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?Nat Rev Neurol2021; 17: 157–172.
34.
CheignonCTomasMBonnefont-RousselotD, et al.Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol2018; 14: 450–464.
35.
LiuXYamashitaTShangJ, et al.Clinical and pathological benefit of Twendee X in Alzheimer's disease transgenic mice with chronic cerebral hypoperfusion. J Stroke Cerebrovasc Dis2019; 28: 1993–2002.
36.
ShiXOhtaYLiuX, et al.Chronic cerebral hypoperfusion activates the coagulation and complement cascades in Alzheimer's disease mice. Neuroscience2019; 416: 126–136.
37.
BianZYamashitaTShiX, et al.rjr. Brain Res2021; 1767: 147569.
38.
ZhangJWuQJinF, et al.Effects of Dendrobium nobile total alkaloids on lipopolysaccharide-induced astrocyte activation and pro-inflammatory factors production. Chin Pharm Bull2021; 27: 824–828.
39.
LiuJLiuBHeX, et al.Dendrobium nobile Lindl. alkaloids suppress NF-kB and NLRP3 signaling pathways to attenuate lipopolysaccharide-induced neuroinflammation. J Cell Signal2020; 1: 102–114.
40.
ZhangWWuQLuYL, et al.Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25-35)-induced neuronal injury. Neural Regen Res2017; 12: 1131–1136.
41.
NieJTianYZhangY, et al.Dendrobium alkaloids prevent Aβ(25-35)-induced neuronal and synaptic loss via promoting neurotrophic factors expression in mice. PeerJ2016; 4: e2739.
42.
LiLSLuYLNieJ, et al.Dendrobium nobile Lindl alkaloid, a novel autophagy inducer, protects against axonal degeneration induced by Aβ(25-35) in hippocampus neurons in vitro. CNS Neurosci Ther2017; 23: 329–340.
43.
XianSYangYNanN, et al.Inhibition of mitochondrial ROS-mediated necroptosis by Dendrobium nobile Lindl. alkaloids in carbon tetrachloride induced acute liver injury. J Ethnopharmacol2024; 330: 118253.
44.
ZhouJZhangYLiS, et al.Dendrobium nobile Lindl. alkaloids-mediated protection against CCl(4-) -induced liver mitochondrial oxidative damage is dependent on the activation of Nrf2 signaling pathway. Biomed Pharmacother2020; 129: 110351.
45.
ChaoM-REvansMDHuC-W, et al.Biomarkers of nucleic acid oxidation – A summary state-of-the-art. Redox Biol2021; 42: 101872.
